Slovenia

Study populations 

Slovenia, in 2016, had an estimated population of just over 2m with 18% being over the age of 65 years and 15% under 15 years of age. By 2050, population projections suggest a decrease in the population and with it a significant change in the age distribution, 32% of the population will be over the age of 65.

Alongside the ageing population, diabetes prevalence is increasing – with the most recent statistics reporting 168,200 people living with the condition and an estimated 63,500 undiagnosed cases.

Report & Infographic 

Cover page for Slovenia Study Report. For accessible PDF version of full report click the image.
Info-graphic containing overview of findings. For an accessible PDF please click the image.

Time of presentation for screening with an ophthamologist

63.9% In time for screening, 36.4% When visual problems have already occurred, 0% Too late for effective treatment
(Ophthamologists n=11)
In time for screening When visual problems have already occurred Too late for effective treatment

Percentage of health care providers who share patient data with other health care providers to optimize patient care

68.4% Yes, 26.3% No, 5.3% Don’t know
(All providers n=19)
Yes
No
Don’t know

Complications adults with diabetes were most concerned about

47.4% Vision loss, 19.3% Amputation, 14% Cardiovascular disease/stroke, 8.8% Kidney disease
(Adults with diabetes n=57)
Vision loss Amputation Cardiovascular disease/stroke Kidney disease

Frequency of discussions about eye complications with health care providers

28.1% Every visit, 7% Multiple times per year, 43.9% Once a year, 7% When symptoms arise, 10.5% Never
(Adults with diabetes n=57)
Every visit Multiple times per year Once a year When symptoms arise Never
banner-join-community

The DR Barometer Community is a growing multidisciplinary network of thought leaders and organizations who are working together to address gaps in diabetes patient care. Join today to help improve vision health outcomes among people living with diabetes.